Market Cap 44.84M
Revenue (ttm) 0.00
Net Income (ttm) -22.73M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 119,100
Avg Vol 431,738
Day's Range N/A - N/A
Shares Out 17.05M
Stochastic %K 51%
Beta -1.15
Analysts Strong Sell
Price Target $24.50

Company Profile

Veru Inc., a late clinical stage biopharmaceutical company, focuses on developing medicines for treatment of metabolic diseases, oncology, and viral-induced acute respiratory distress syndrome (ARDS) in Florida and internationally. It provides FC2 female condom for the dual protection against unplanned pregnancy and the transmission of sexually transmitted infections. The company develops enobosarm, a selective androgen receptor modulator for treatment of augment fat loss and to prevent muscle l...

Industry: Biotechnology
Sector: Healthcare
Phone: 305 509 6897
Address:
2916 North Miami Avenue, Suite 1000, Miami, United States
justFrog
justFrog Aug. 18 at 4:07 PM
$MAJI interesting product tease.... I'm curious how this one compares to what $VERU is testing. https://x.com/NexTelMedical/status/2089733025730863214
0 · Reply
mrkymrk
mrkymrk Aug. 17 at 8:45 PM
$VERU am I reading this 8-k correctly? Gary Barnett bought a measly 1,800 shares? Like $5K worth of stock. As an officer of the company, WTF is the point of that?
3 · Reply
Zephix
Zephix Aug. 13 at 11:05 PM
$VERU Cig1
0 · Reply
cray1965
cray1965 Aug. 13 at 10:24 PM
$VERU Yes, you can't spell it out better than that. Cramer says a coform that burns fat not muscle is the 'Holy grail.' Enobosarm and Lilly's drug Enobosarm are both small molecule, much easier to coform. Novo's pill could also be coformed with Enobo, but not as easily. And yes, Doustdar didn't engage on the Holy Grail pill, which could/would make sense if they are in talks. In short, both companies have huge reasons to want Veru and Enobosarm. Let's see what Mitch can do. Also, check out the Canaccord fireside chat with Mitch on Veru's website. Interesting what Mitch says- and what he doesn't say.
2 · Reply
GenralZod
GenralZod Aug. 13 at 12:55 PM
$VERU for what it's worth. Cramer sat with NOVO CEO. Some chat about legal and then clinical trials and Cramer leans in with -pill burns fat and preservers muscle is the "Holy Grail" Mr.Doustdar brushes it aside stating not worried about any 1 specific trail... btw %90 of Novo is the glp-1 business. um yeah. He should be all in behind the scenes.
1 · Reply
BluntForceOptions
BluntForceOptions Aug. 11 at 5:50 PM
$VERU Position update/technical layout: Not a new name here. Initiated my core exposure back in the mid-$2 s and aggressively added on that recent dip into the $2.20 zone to lower my basis. The technical posture is resolving to the upside nicely. Price has cleared and is holding above its 200-day SMA ($2.51), with indicators expanding out of the base as the structure solidifies. I expect a move into a 3-handle in the near term, followed by an eventual push into 4-handle territory as the multi-month structure unwinds. Key Technical Targets (as marked on my chart): • R-1 / PT1: $3.26 • R-2 / PT2: $4.49 Risk is strictly defined at the base... now just letting the setup work. NFA. Please do your own DD.
0 · Reply
cray1965
cray1965 Aug. 11 at 3:43 AM
$VERU Take aways from earnings call. 1. Dementia progressing in Mitch. Maybe if Lilly buys them he’ll get a free prescription for Kisunla. 2. They didn’t use the ATM. That’s a good thing. 3. Maintained 32 week interim, which makes a near term transaction more advantageous because interim won’t even hit plateau, won’t show incremental weight loss and will probably hit the stock 4. Still only one analyst question(like last 3 earning calls), from Oppenheimer, Veru’s banker(like last 3 earning calls), and oddly no questions about partnering. Hmm. 5. Steiner mentioned Semaglutide patent and ROFN with Novo(for first time) that allows Novo to monitor trial and gives Veru ‘a direct channel into the Novo Nordisk conglomerate.’ Is he talking to Novo- or to Lilly?
2 · Reply
PlankieWalk
PlankieWalk Aug. 11 at 12:44 AM
$VERU why Issit rising? There is no new development? Everything g is the same. Please enlighten me
1 · Reply
Synaptric
Synaptric Aug. 10 at 9:26 PM
From this morning's reporting companies, the largest fall $BTDR was from the Bullish zone. The other two double-digit moves, were equally neutral at 55 $VERU and $CEVA but went different directions.
0 · Reply
GenralZod
GenralZod Aug. 10 at 4:58 PM
$VERU the dump is next. I've listened to Mitch for years. Dating back to GTXi. His decline in speaking is a sad part of life. As will be the dump. Wish him the best and will welcome in his replacement. Keep him in some role give him his due. Enobosarm is his baby. His VERU legacy, if...
1 · Reply
Latest News on VERU
Veru Inc. Earnings Call Transcript: Q3 2026

Aug 10, 2026, 8:00 AM EDT - 9 days ago

Veru Inc. Earnings Call Transcript: Q3 2026


Veru Inc. Earnings release: Q3 2026

Aug 10, 2026, 8:00 AM EDT - 9 days ago

Veru Inc. Earnings release: Q3 2026


Veru Inc. Quarterly report: Q3 2026

Aug 10, 2026, 8:00 AM EDT - 9 days ago

Veru Inc. Quarterly report: Q3 2026


Veru reports Q3 EPS (30c) vs. (50c) last year

2026-08-10T10:41:41.000Z - 9 days ago

Veru reports Q3 EPS (30c) vs. (50c) last year


Veru completes enrollment in PLATEAU clinical study

2026-07-27T13:11:09.000Z - 23 days ago

Veru completes enrollment in PLATEAU clinical study


Veru pact with Novo ‘significant event,’ says Canaccord

2026-06-04T16:45:29.000Z - 2 months ago

Veru pact with Novo ‘significant event,’ says Canaccord

NVO


Veru announces clinical supply agreement with Novo Nordisk

2026-06-04T16:40:26.000Z - 2 months ago

Veru announces clinical supply agreement with Novo Nordisk

NVO


Veru price target lowered to $24 from $25 at Oppenheimer

2026-05-15T14:08:45.000Z - 3 months ago

Veru price target lowered to $24 from $25 at Oppenheimer


Veru Inc. Earnings Call Transcript: Q2 2026

May 13, 2026, 8:00 AM EDT - 3 months ago

Veru Inc. Earnings Call Transcript: Q2 2026


Veru Inc. Earnings release: Q2 2026

May 13, 2026, 8:00 AM EDT - 3 months ago

Veru Inc. Earnings release: Q2 2026


Veru Inc. Quarterly report: Q2 2026

May 13, 2026, 8:00 AM EDT - 3 months ago

Veru Inc. Quarterly report: Q2 2026


Veru files $200M mixed securities shelf

2026-04-07T20:25:46.000Z - 4 months ago

Veru files $200M mixed securities shelf


Veru files to sell 23.8M shares of common stock

2026-04-07T20:22:21.000Z - 4 months ago

Veru files to sell 23.8M shares of common stock


Veru Inc. Registration statement: Registration filing

Apr 7, 2026, 8:00 AM EDT - 4 months ago

Veru Inc. Registration statement: Registration filing


Veru Inc. Registration statement: Registration filing

Apr 7, 2026, 8:00 AM EDT - 4 months ago

Veru Inc. Registration statement: Registration filing


Veru Inc. Earnings Call Transcript: Q1 2026

Feb 11, 2026, 8:00 AM EST - 6 months ago

Veru Inc. Earnings Call Transcript: Q1 2026


Veru Inc. Quarterly report: Q1 2026

Feb 11, 2026, 8:00 AM EST - 6 months ago

Veru Inc. Quarterly report: Q1 2026


Veru Inc. Earnings release: Q1 2026

Feb 11, 2026, 8:00 AM EST - 6 months ago

Veru Inc. Earnings release: Q1 2026


Veru Inc. Quarterly report: Q1 2026

Feb 11, 2026, 8:00 AM EST - 6 months ago

Veru Inc. Quarterly report: Q1 2026


Veru Inc. Proxy statement: Proxy Filing

Jan 28, 2026, 7:00 AM EST - 7 months ago

Veru Inc. Proxy statement: Proxy Filing


Veru Inc. Proxy statement: Proxy Filing

Jan 28, 2026, 7:00 AM EST - 7 months ago

Veru Inc. Proxy statement: Proxy Filing


Veru initiated with a Buy at Canaccord

2025-12-18T11:11:56.000Z - 8 months ago

Veru initiated with a Buy at Canaccord


Veru Inc. Earnings Call Transcript: Q4 2025

Dec 17, 2025, 8:00 AM EST - 8 months ago

Veru Inc. Earnings Call Transcript: Q4 2025


Veru Inc. Annual report: Q4 2025

Dec 17, 2025, 8:00 AM EST - 8 months ago

Veru Inc. Annual report: Q4 2025


Veru Inc. Earnings release: Q4 2025

Dec 17, 2025, 8:00 AM EST - 8 months ago

Veru Inc. Earnings release: Q4 2025


Veru Inc. Slides: Investor presentation

Nov 19, 2025, 5:24 PM EST - 9 months ago

Veru Inc. Slides: Investor presentation


Veru to Present Two Abstracts at ObesityWeek 2025

Oct 31, 2025, 8:30 AM EDT - 10 months ago

Veru to Present Two Abstracts at ObesityWeek 2025


Veru prices 1.4M shares at $3.00 in underwritten public offering

2025-10-30T12:31:52.000Z - 10 months ago

Veru prices 1.4M shares at $3.00 in underwritten public offering


Veru announces pricing of $25M public offering

2025-10-30T12:26:38.000Z - 10 months ago

Veru announces pricing of $25M public offering


Veru Announces Proposed Public Offering

Oct 29, 2025, 4:01 PM EDT - 10 months ago

Veru Announces Proposed Public Offering


Veru Inc. Earnings Call Transcript: Q3 2025

Aug 12, 2025, 8:00 AM EDT - 1 year ago

Veru Inc. Earnings Call Transcript: Q3 2025


Veru Inc. Quarterly report: Q3 2025

Aug 12, 2025, 8:00 AM EDT - 1 year ago

Veru Inc. Quarterly report: Q3 2025


Veru Inc. Earnings release: Q3 2025

Aug 12, 2025, 8:00 AM EDT - 1 year ago

Veru Inc. Earnings release: Q3 2025


Veru Announces Reverse Stock Split

Aug 6, 2025, 8:30 AM EDT - 1 year ago

Veru Announces Reverse Stock Split


Veru Inc. Proxy statement: Proxy Filing

Jul 15, 2025, 8:00 AM EDT - 1 year ago

Veru Inc. Proxy statement: Proxy Filing


Veru to Participate in the Virtual BTIG Obesity Health Forum

Jun 11, 2025, 8:30 AM EDT - 1 year ago

Veru to Participate in the Virtual BTIG Obesity Health Forum


Veru Inc. Proxy statement: Proxy Filing

Jun 10, 2025, 8:00 AM EDT - 1 year ago

Veru Inc. Proxy statement: Proxy Filing


Veru Inc. Proxy statement: Proxy Filing

Jun 10, 2025, 8:00 AM EDT - 1 year ago

Veru Inc. Proxy statement: Proxy Filing


Veru Inc. Proxy statement: Proxy Filing

May 9, 2025, 8:00 AM EDT - 1 year ago

Veru Inc. Proxy statement: Proxy Filing


Veru Participates in a Virtual Investor KOL Connect Segment

May 8, 2025, 9:25 AM EDT - 1 year ago

Veru Participates in a Virtual Investor KOL Connect Segment


Veru Inc. Earnings Call Transcript: Q2 2025

May 8, 2025, 8:00 AM EDT - 1 year ago

Veru Inc. Earnings Call Transcript: Q2 2025


Veru Inc. Quarterly report: Q2 2025

May 8, 2025, 8:00 AM EDT - 1 year ago

Veru Inc. Quarterly report: Q2 2025


Veru Inc. Earnings release: Q2 2025

May 8, 2025, 8:00 AM EDT - 1 year ago

Veru Inc. Earnings release: Q2 2025


Veru Inc. Earnings Call Transcript: Q1 2025

Feb 13, 2025, 8:00 AM EST - 1 year ago

Veru Inc. Earnings Call Transcript: Q1 2025


Veru Inc. Quarterly report: Q1 2025

Feb 13, 2025, 8:00 AM EST - 1 year ago

Veru Inc. Quarterly report: Q1 2025


Veru Inc. Earnings release: Q1 2025

Feb 13, 2025, 8:00 AM EST - 1 year ago

Veru Inc. Earnings release: Q1 2025


Veru Inc. Proxy statement: Proxy Filing

Jan 28, 2025, 7:00 AM EST - 1 year ago

Veru Inc. Proxy statement: Proxy Filing


Veru Inc. Proxy statement: Proxy Filing

Jan 28, 2025, 7:00 AM EST - 1 year ago

Veru Inc. Proxy statement: Proxy Filing


Veru Inc. Transcript: Study Result

Jan 26, 2025, 7:00 PM EST - 1 year ago

Veru Inc. Transcript: Study Result


Veru Inc. Press release: Study Result

Jan 26, 2025, 7:00 PM EST - 1 year ago

Veru Inc. Press release: Study Result


Veru Inc. Annual report: Q4 2024

Dec 16, 2024, 12:00 AM EST - 1 year ago

Veru Inc. Annual report: Q4 2024


Veru to Present at the 2024 Cantor Global Healthcare Conference

Sep 11, 2024, 8:30 AM EDT - 2 years ago

Veru to Present at the 2024 Cantor Global Healthcare Conference


Veru Inc. Earnings Call Transcript: Q3 2024

Aug 8, 2024, 8:00 AM EDT - 2 years ago

Veru Inc. Earnings Call Transcript: Q3 2024


Veru Inc. Quarterly report: Q3 2024

Aug 8, 2024, 8:00 AM EDT - 2 years ago

Veru Inc. Quarterly report: Q3 2024


Veru Inc. Earnings release: Q3 2024

Aug 8, 2024, 8:00 AM EDT - 2 years ago

Veru Inc. Earnings release: Q3 2024


Veru Inc. Proxy statement: Proxy Filing

Jun 20, 2024, 8:00 AM EDT - 2 years ago

Veru Inc. Proxy statement: Proxy Filing


Veru Inc. Proxy statement: Proxy Filing

Jun 18, 2024, 8:00 AM EDT - 2 years ago

Veru Inc. Proxy statement: Proxy Filing


Veru Inc. Transcript: Jefferies Global Healthcare Conference

Jun 5, 2024, 11:00 AM EDT - 2 years ago

Veru Inc. Transcript: Jefferies Global Healthcare Conference


Veru to Present at the Jefferies Global Healthcare Conference

May 22, 2024, 8:30 AM EDT - 2 years ago

Veru to Present at the Jefferies Global Healthcare Conference


Veru Announces Steven B. Heymsfield M.D.

May 15, 2024, 8:30 AM EDT - 2 years ago

Veru Announces Steven B. Heymsfield M.D.


Veru Inc. Proxy statement: Proxy Filing

May 9, 2024, 8:00 AM EDT - 2 years ago

Veru Inc. Proxy statement: Proxy Filing


Veru Inc. Proxy statement: Proxy Filing

May 9, 2024, 8:00 AM EDT - 2 years ago

Veru Inc. Proxy statement: Proxy Filing


Veru Inc. Earnings Call Transcript: Q2 2024

May 8, 2024, 8:00 AM EDT - 2 years ago

Veru Inc. Earnings Call Transcript: Q2 2024


Veru Inc. Quarterly report: Q2 2024

May 8, 2024, 8:00 AM EDT - 2 years ago

Veru Inc. Quarterly report: Q2 2024


Veru Inc. Earnings release: Q2 2024

May 8, 2024, 8:00 AM EDT - 2 years ago

Veru Inc. Earnings release: Q2 2024


Veru Inc. Slides: Q2 2024

May 8, 2024, 8:00 AM EDT - 2 years ago

Veru Inc. Slides: Q2 2024


Veru to Present at the GLP-1 Based Therapeutics Summit

May 2, 2024, 8:30 AM EDT - 2 years ago

Veru to Present at the GLP-1 Based Therapeutics Summit


justFrog
justFrog Aug. 18 at 4:07 PM
$MAJI interesting product tease.... I'm curious how this one compares to what $VERU is testing. https://x.com/NexTelMedical/status/2089733025730863214
0 · Reply
mrkymrk
mrkymrk Aug. 17 at 8:45 PM
$VERU am I reading this 8-k correctly? Gary Barnett bought a measly 1,800 shares? Like $5K worth of stock. As an officer of the company, WTF is the point of that?
3 · Reply
Zephix
Zephix Aug. 13 at 11:05 PM
$VERU Cig1
0 · Reply
cray1965
cray1965 Aug. 13 at 10:24 PM
$VERU Yes, you can't spell it out better than that. Cramer says a coform that burns fat not muscle is the 'Holy grail.' Enobosarm and Lilly's drug Enobosarm are both small molecule, much easier to coform. Novo's pill could also be coformed with Enobo, but not as easily. And yes, Doustdar didn't engage on the Holy Grail pill, which could/would make sense if they are in talks. In short, both companies have huge reasons to want Veru and Enobosarm. Let's see what Mitch can do. Also, check out the Canaccord fireside chat with Mitch on Veru's website. Interesting what Mitch says- and what he doesn't say.
2 · Reply
GenralZod
GenralZod Aug. 13 at 12:55 PM
$VERU for what it's worth. Cramer sat with NOVO CEO. Some chat about legal and then clinical trials and Cramer leans in with -pill burns fat and preservers muscle is the "Holy Grail" Mr.Doustdar brushes it aside stating not worried about any 1 specific trail... btw %90 of Novo is the glp-1 business. um yeah. He should be all in behind the scenes.
1 · Reply
BluntForceOptions
BluntForceOptions Aug. 11 at 5:50 PM
$VERU Position update/technical layout: Not a new name here. Initiated my core exposure back in the mid-$2 s and aggressively added on that recent dip into the $2.20 zone to lower my basis. The technical posture is resolving to the upside nicely. Price has cleared and is holding above its 200-day SMA ($2.51), with indicators expanding out of the base as the structure solidifies. I expect a move into a 3-handle in the near term, followed by an eventual push into 4-handle territory as the multi-month structure unwinds. Key Technical Targets (as marked on my chart): • R-1 / PT1: $3.26 • R-2 / PT2: $4.49 Risk is strictly defined at the base... now just letting the setup work. NFA. Please do your own DD.
0 · Reply
cray1965
cray1965 Aug. 11 at 3:43 AM
$VERU Take aways from earnings call. 1. Dementia progressing in Mitch. Maybe if Lilly buys them he’ll get a free prescription for Kisunla. 2. They didn’t use the ATM. That’s a good thing. 3. Maintained 32 week interim, which makes a near term transaction more advantageous because interim won’t even hit plateau, won’t show incremental weight loss and will probably hit the stock 4. Still only one analyst question(like last 3 earning calls), from Oppenheimer, Veru’s banker(like last 3 earning calls), and oddly no questions about partnering. Hmm. 5. Steiner mentioned Semaglutide patent and ROFN with Novo(for first time) that allows Novo to monitor trial and gives Veru ‘a direct channel into the Novo Nordisk conglomerate.’ Is he talking to Novo- or to Lilly?
2 · Reply
PlankieWalk
PlankieWalk Aug. 11 at 12:44 AM
$VERU why Issit rising? There is no new development? Everything g is the same. Please enlighten me
1 · Reply
Synaptric
Synaptric Aug. 10 at 9:26 PM
From this morning's reporting companies, the largest fall $BTDR was from the Bullish zone. The other two double-digit moves, were equally neutral at 55 $VERU and $CEVA but went different directions.
0 · Reply
GenralZod
GenralZod Aug. 10 at 4:58 PM
$VERU the dump is next. I've listened to Mitch for years. Dating back to GTXi. His decline in speaking is a sad part of life. As will be the dump. Wish him the best and will welcome in his replacement. Keep him in some role give him his due. Enobosarm is his baby. His VERU legacy, if...
1 · Reply
StocktwitsNews
StocktwitsNews Aug. 10 at 4:33 PM
VERU Q3 2026 Earnings Summary $VERU https://stocktwits.com/news/earnings/ai summaries/veru-q3-2026-earnings-summary/cZojvYzRJOy
0 · Reply
algo888
algo888 Aug. 10 at 4:10 PM
$VERU see y'all @ $7.00 again...
0 · Reply
algo888
algo888 Aug. 10 at 4:02 PM
$VERU recovering, lets break it above 3.00
0 · Reply
Bullish_Visions
Bullish_Visions Aug. 10 at 3:41 PM
AIFA has the look, the chart+the DD to make a big rally soon. Make sure to put AIFA on ur watch! Always best to position ur self early on these parabolic setups. $FEAM $ABCL $SVRN $VERU , next up AIFA.
0 · Reply
Eesnimi
Eesnimi Aug. 10 at 3:30 PM
$VERU OK price is 30-50. Under 10 it is absolute garbage
1 · Reply
algo888
algo888 Aug. 10 at 3:20 PM
$VERU last chance to load up below 3.00
0 · Reply
algo888
algo888 Aug. 10 at 3:18 PM
$VERU added @ 2.84
0 · Reply
algo888
algo888 Aug. 10 at 3:16 PM
$VERU 2.85 It's a go!!!!
0 · Reply
algo888
algo888 Aug. 10 at 3:14 PM
0 · Reply
French_Vibe
French_Vibe Aug. 10 at 1:58 PM
$VERU No news = good news, I added more at the opening.
1 · Reply
STACKD0E
STACKD0E Aug. 10 at 1:58 PM
$VERU 👁️
0 · Reply
mrkymrk
mrkymrk Aug. 10 at 1:53 PM
$VERU imagine where we would be if our CEO could complete a sentence
0 · Reply